ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements
Roshan Dealmark Private Limited (Promoter Group) sold 700,000 equity shares of Tavexia Lifecare Ltd via market sale on September 25, 2026.
Promoter Group entity, Roshan Dealmark Private Limited, sold 2,00,000 shares of Tavexia Lifecare Ltd in the open market, aggregating to ₹0.02 Crore.
Promoter group entity Roshan Dealership Private Limited sold 4,00,000 Tavexia Lifecare shares on BSE for ₹0.05 Crore. Stake reduced from 4.03% to 3.93%.
Promoter Roshan Dealmark Pvt Ltd sold 4,00,000 Tavexia Lifecare shares on-market on 23.09.2026. Its stake fell from 4.051% to 3.947%, a 0.104% reduction.
Roshan Dealmark, a promoter group entity, sold 9,07,105 shares of Tavexia Lifecare on BSE for Rs. 0.11 Crore. Stake reduced from 4.27% to 4.03%.
Roshan Dealmark Private Limited (Promoter Group) sold 2,80,000 equity shares of Tavexia Lifecare Ltd through a market sale on the BSE. The transaction value was ₹0.03 Crore.
Roshan Dealmark Private Limited, part of the Promoter Group, sold 10 lakh shares of Tavexia Lifecare Ltd for ₹0.12 Crore via market sale.
Promoter Group entity Roshan Dealmark Private Limited sold 8,01,878 equity shares of Tavexia Lifecare Ltd via market sale on BSE, reducing its stake by 0.21%.
Roshan Dealmark, a promoter, disposed 14,00,000 Tavexia Lifecare shares on-market on 15 Sep 2026, cutting its stake from 5.19% to 4.83%.
Promoter group entity Roshan Dealmark sold 18 lakh shares of Tavexia Lifecare via market sale. The sale reduces the promoter's stake by 0.47%.
Roshan Dealmark Private Limited (Promoter Group) sold 14,00,000 equity shares of Tavexia Lifecare Ltd for ₹0.16 Crore via an open market transaction.
Tavexia Lifecare Limited has submitted its 46th Annual Report for the Financial Year 2025-2026, which includes the notice for the upcoming Annual General Meeting.
Tavexia Lifecare Limited announced the closure of its register of members from September 24 to September 30, 2026, for the 46th Annual General Meeting.
Tavexia Lifecare announced board meeting outcomes, including statutory auditor changes, independent director reappointment, and a proposal to explore acquiring a 60% stake in Meyonex Pharmaceuticals.
Tavexia Lifecare Limited announced the resignation of its statutory auditor, M/s. SSRV and Associates, effective September 7, 2026, due to professional and administrative reasons.
Promoter Roshan Dealmark disposed 14,00,000 Tavexia Lifecare shares in the open market. Its stake fell from 6.39% to 6.02%, a 0.36% reduction.
Roshan Dealmark Private Limited, a promoter group entity, sold 14,00,000 equity shares of Tavexia Lifecare Ltd via market sale. The transaction value is Rs. 14 Lakhs.
Sattva Sukun Lifecare Ltd reported revenue from operations of ₹0.6 Cr (-50.0% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
Sattva Sukun Lifecare Ltd reported revenue from operations of ₹8.5 Cr (+672.7% YoY) and a net loss of ₹0.7 Cr for Q4 FY26.